Kaposi's sarcoma herpesvirus seroprevalence among blood donors in Uganda
Transfusion · 2025
DOI: 10.1111/trf.18236 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, 2025. Verfasst von Tait Huso und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Herpesvirus 8, Human, Blood Donors, Antibodies, Viral, Sarcoma, Kaposi. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDDK NIH HHS, Division of Intramural Research, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Background
Kaposi's sarcoma herpesvirus (KSHV) causes a life‐long infection that can progress to several types of KSHV‐associated diseases. There is evidence for transfusion transmission of KSHV. In endemic regions, such as sub‐Saharan African, KSHV seroprevalence is >40%. However, previous studies of blood donors utilized immunoassays that detect KSHV‐associated disease‐specific antigens, which may underestimate the true burden of KSHV in a healthy population. Study Design and Methods We utilized samples from an on‐going transfusion transmitted infection clinical trial to estimate the seroprevalence of KSHV among 4921 blood donations from healthy donors in Uganda collected between October 2019 and December 2022. A multiplexed bead‐based assay was used to measure plasma IgG against five antigens encoded by the K8.1, K10.5, ORF73, ORF38, and ORF25 genes of KSHV. Significant associations between donor characteristics and seroprevalence were assessed by chi‐square tests.
Results
Overall, KSHV seroprevalence was 69.1%. Seroprevalence was higher in units collected from older donors compared with younger donors and male donors (71.9% [95% confidence interval (CI) = 70.4%–73.3%]) compared with female donors (61.3% [95% CI = 58.6%–64.0%]; p < .001). KSHV seroprevalnce was higher among units collected from donors positive for T. pallidum (82.5% [95% CI = 73.8%–89.3%]) compared with units collected from donors who were negative (68.8% [95% CI = 67.5%–70.1%]; p < .001). KSHV seroprevalence was higher in units that tested positive for HIV, HBV, or HCV, though these results were not statistically significant.
Conclusion
Given the high seroprevalence and limited availability of lab assays that detect active KSHV infections, methods such as leukoreduction or pathogen reduction should be considered to potentially reduce the risk of transfusion transmission of KSHV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
- Uganda Blood Transfusion Services, Kampala, Uganda.
- Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
- MUJHU Research Collaboration, Kampala, Uganda.
- Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA.
- Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
ORCID-Profile: Raymond Goodrich, Aggrey Dhabangi, Evan M Bloch, Aaron A R Tobian
Förderung
- NCI NIH HHS
- NIDDK NIH HHS
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- NHLBI NIH HHS
- U.S. Department of Defense
- Frederick National Laboratory for Cancer Research
- National Heart, Lung, and Blood Institute
- National Cancer Institute
Zitieren
APA
Huso, T., White, J. L., Kyeyune, D., D'Adamo, A., Labo, N., Miley, W., Musisi, E., Moses, K., Kasirye, R., Lubega, I., Wambongo Musana, H., Eroju, P., Motevalli, M., Goodrich, R., Grabowski, M. K., Quinn, T. C., Ness, P. M., Hume, H. A., Ddungu, H., …, & Tobian, A. A. R. (2025). Kaposi's sarcoma herpesvirus seroprevalence among blood donors in Uganda. Transfusion. https://doi.org/10.1111/trf.18236
Vancouver
Huso T, White JL, Kyeyune D, D'Adamo A, Labo N, Miley W, et al. Kaposi's sarcoma herpesvirus seroprevalence among blood donors in Uganda. Transfusion. 2025. doi:10.1111/trf.18236
BibTeX
@article{Huso2025,
author = {Huso, Tait and White, Jodie L and Kyeyune, Dorothy and D'Adamo, Angela and Labo, Nazzarena and Miley, Wendell and Musisi, Ezra and Moses, Khan and Kasirye, Ronnie and Lubega, Irene and Wambongo Musana, Hellen and Eroju, Priscilla and Motevalli, Mahnaz and Goodrich, Raymond and Grabowski, M Kate and Quinn, Thomas C and Ness, Paul M and Hume, Heather A and Ddungu, Henry and Dhabangi, Aggrey and Bloch, Evan M and Fowler, Mary Glenn and Musoke, Philippa and Whitby, Denise and Tobian, Aaron A R},
title = {Kaposi's sarcoma herpesvirus seroprevalence among blood donors in Uganda},
journal = {Transfusion},
year = {2025},
doi = {10.1111/trf.18236}
}
EUVIMED